Taken together, our results in Il22-/- mice show that IL-22 limits pathology during cutaneous leishmaniasis and suggest that once a certain threshold of damage is reached, IL-22 is expressed at higher levels and limits subsequent damage by maintaining skin barrier integrity and wound healing capacities. Here, IL22 is linked to cutaneous leishmaniasis.